Concepedia

Tadeusz Pieńkowski

TP

80

Publications

25.3K

Citations

49

H-Index

1991

Active since

Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology(Current)

Postgraduate School of Molecular Medicine

Samsung Medical Center

Roche (Switzerland)

Cancer Trials Ireland

Tadeusz Pieńkowski is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in medicine, oncology, and breast cancer.

ORCID

Top concepts

Publications per year

1991–2024

80

Publications

80

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

Charles E. Geyer, John Forster, Deborah Lindquist et al. · New England Journal of Medicine · 2006 · 3.4K citations · Full text

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

Dennis J. Slamon, W. Eiermann, Nicholas J. Robert et al. · New England Journal of Medicine · 2011 · 2.7K citations · Full text

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

José Baselga, Javier Cortés, Sung‐Bae Kim et al. · New England Journal of Medicine · 2011 · 2.5K citations · Full text

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology · 2011 · 2.3K citations

, , +7

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

Christina Davies, Hongchao Pan, Jon Godwin et al. · The Lancet · 2012 · 2K citations · Full text

, , +7

Rows per page

1–5 of 80